- Report
- April 2025
- 192 Pages
Global
From €5317EUR$5,850USD£4,553GBP
- Report
- March 2024
- 144 Pages
Global
From €2726EUR$2,999USD£2,334GBP
- Report
- April 2023
- 111 Pages
Global
From €4317EUR$4,750USD£3,697GBP
- Report
- January 2024
- 250 Pages
Global
€4540EUR$4,995USD£3,888GBP
- Report
- February 2024
- 87 Pages
Global
From €3500EUR$4,125USD£3,102GBP
- Report
- April 2025
- 50 Pages
Global
From €2409EUR$2,650USD£2,062GBP
- Report
- April 2025
- 50 Pages
Global
From €2409EUR$2,650USD£2,062GBP
Pravastatin is a cholesterol-lowering medication used to treat cardiovascular diseases. It belongs to a class of drugs known as statins, which work by blocking an enzyme in the liver that is responsible for producing cholesterol. Pravastatin is used to reduce the risk of heart attack, stroke, and other cardiovascular events in people with high cholesterol levels. It is also used to reduce the risk of developing heart disease in people with certain risk factors, such as diabetes, high blood pressure, or a family history of heart disease.
Pravastatin is available in both generic and brand-name formulations. It is typically taken once daily, with or without food. Common side effects include headache, nausea, and muscle pain.
The pravastatin market is highly competitive, with a number of companies offering generic and brand-name formulations. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and Mylan. Show Less Read more